In vitro characterization of the alpha-adrenoceptors in human prostate

Eur J Pharmacol. 1985 Jan 2;107(2):111-7. doi: 10.1016/0014-2999(85)90048-2.

Abstract

The alpha-adrenoceptors of the human prostate gland were characterized in vitro by the use of antagonists selective for alpha 1- and alpha 2-adrenoceptor subtypes. The contractile response induced by norepinephrine in this tissue could be antagonized by prazosin, a selective alpha 1-antagonist, with a receptor dissociation constant (KB) of 4.0 +/- 0.9 nM. The selective alpha 2-antagonists rauwolscine and SK&F 86466 were less potent antagonists of this response, with KB values of 1020 +/- 400 nM and 2400 +/- 800 nM, respectively. The irreversible alpha-antagonists benextramine and phenoxybenzamine, both of which preferentially inactivate the alpha 1-subtype, produced marked depression of norepinephrine-induced contraction. These data would suggest that the alpha-receptors on prostatic smooth muscle are predominantly of the alpha 1-subtype.

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology
  • Dose-Response Relationship, Drug
  • Humans
  • In Vitro Techniques
  • Male
  • Muscle Contraction / drug effects
  • Norepinephrine / pharmacology
  • Prazosin / pharmacology
  • Prazosin / therapeutic use
  • Prostate / analysis*
  • Prostate / drug effects
  • Prostatic Hyperplasia / drug therapy
  • Receptors, Adrenergic, alpha / analysis*
  • Receptors, Adrenergic, alpha / drug effects

Substances

  • Adrenergic alpha-Antagonists
  • Receptors, Adrenergic, alpha
  • Norepinephrine
  • Prazosin